Gayle A. Brazeau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gayle A. Brazeau has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey A. Hughes
University of Florida, College of Pharmacy
3 shared publicationsCharles L. Smith
Parker E. Mahan Facial Pain Center, College of Dentistry, Box 100437, JHMHC, University of Florida Gainesville, Florida 32610
2 shared publicationsAndre P. Mauderli
Associate professor, in the Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville
1 shared publicationBrian Cooper
Department of Oral and Maxillary Surgery and Diagnostic Sciences, College of Dentistry, Box 100416, University of Florida Gainesville, Florida 32610
1 shared publicationCharles G. Widmer
Associate professor, in the Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville
1 shared publicationHenry A. Gremillion
Associate professor, in the Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville
1 shared publication
Latest Publications
- 1 June 1998
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (6) , 667-677
Current Perspectives on Pain upon Injection of Drugs
A limitation in the administration of parenteral products is the pain caused upon injection. Injection site pain has been predominately associated with intravenous, intramuscular, and subcutaneous administration. It becomes important for the formulation scientist to have a basic understanding of the physiology underlying the pain process, as well as the pharmaceutical factors associated with injection site pain. Initially, this review will provide the reader with a primer on the mediation of pain in the periphery and a compilation of those drugs that have been associated with pain on injection. In addition, this review will present important considerations and general formulation approaches or methods that have been used to overcome pain on injection. Finally, a brief overview of the various experimental systems used to investigate injection site pain is discussed.
- 1 June 1998
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (6) , 667-677
Current Perspectives on Pain upon Injection of Drugs
A limitation in the administration of parenteral products is the pain caused upon injection. Injection site pain has been predominately associated with intravenous, intramuscular, and subcutaneous administration. It becomes important for the formulation scientist to have a basic understanding of the physiology underlying the pain process, as well as the pharmaceutical factors associated with injection site pain. Initially, this review will provide the reader with a primer on the mediation of pain in the periphery and a compilation of those drugs that have been associated with pain on injection. In addition, this review will present important considerations and general formulation approaches or methods that have been used to overcome pain on injection. Finally, a brief overview of the various experimental systems used to investigate injection site pain is discussed.
- 1 May 1998
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (5) , 680-684
In Vitro Myotoxicity of Selected Cationic Macromolecules Used in Non-Viral Gene Delivery
Purpose. Cationic lipid/DNA complexes have been proposed as a method of in vivogene delivery via intravenous or intramuscular injection. A concern with using these polycationic molecules is whether...
- 1 May 1998
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (5) , 680-684
In Vitro Myotoxicity of Selected Cationic Macromolecules Used in Non-Viral Gene Delivery
Purpose. Cationic lipid/DNA complexes have been proposed as a method of in vivogene delivery via intravenous or intramuscular injection. A concern with using these polycationic molecules is whether...
- 1 May 1998
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 38 (3) , 354-363
The Role of Pharmacy in the Management of Patients with Temporomandibular Disorders and Orofacial Pain
- 1 May 1998
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 38 (3) , 354-363
The Role of Pharmacy in the Management of Patients with Temporomandibular Disorders and Orofacial Pain
- 1 January 1996
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 36 (1) , 14-15
Vaccines on the Horizon: HIV and Cancer
- 1 January 1996
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 36 (1) , 14-15
Vaccines on the Horizon: HIV and Cancer
- 1 December 1995
- Published by Elsevier in American Pharmacy
- Vol. 35 (12) , 9-10
Genetically Engineered Vaccines
- 1 December 1995
- Published by Elsevier in American Pharmacy
- Vol. 35 (12) , 9-10
Genetically Engineered Vaccines